Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state
- 28 June 2007
- Vol. 25 (27) , 5102-5114
- https://doi.org/10.1016/j.vaccine.2006.09.071
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Functional Solubilization of Aggregation-prone HIV Envelope Proteins by Covalent Fusion with Chaperone ModulesJournal of Molecular Biology, 2005
- Comparison of HIV Type 1 ADA gp120 Monomers versus gp140 Trimers as Immunogens for the Induction of Neutralizing AntibodiesAIDS Research and Human Retroviruses, 2005
- Characterization of the Outer Domain of the gp120 Glycoprotein from Human Immunodeficiency Virus Type 1Journal of Virology, 2004
- Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responsesMolecular Immunology, 2004
- Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational ChangesJournal of Virology, 2004
- Antibody neutralization and escape by HIV-1Nature, 2003
- BAFF: A fundamental survival factor for B cellsNature Reviews Immunology, 2002
- Viral Persistence: HIV's Strategies of Immune System EvasionAnnual Review of Medicine, 2002
- Immunodominant Glycoprotein 41 Epitope Identified by Seroreactivity in HIV Type 1-Infected IndividualsAIDS Research and Human Retroviruses, 1996
- Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions.Journal of Histochemistry & Cytochemistry, 1993